From 1 July Latvia introduces heavier fines for manufacturing and distribution of counterfeit medicines, as well as a failure to perform obligations of the verification system

On 1 July amendments to the Pharmacy Law of the Republic of Latvia came into force that provide for more detailed administrative fines in the field of pharmacy and increase responsibility for manufacturing and distribution of counterfeit medicines.

Compared to the previous regulation in the field of medicinal products for human use fines have been increased, because the offence is potentially dangerous – it could threaten directly the health of people and the society.

Amendments made to the law envision larger fines for persons, who will fail to perform verification of the safety features of medicinal products or obligations established by the verification system of medicinal products. Namely, for a natural person from 30 to 280 fine units, but for a legal entity – from 300 to 2800 fine units.

Larger fines will also be imposed for import, export or distribution of counterfeit medicines or counterfeit active ingredients – imposing on a natural person from 50 to 400 fine units, but on a legal entity – from 500 to 4000 fine units.

Pharmacy Law with amendments is available at: